FEDERAL COURT OF AUSTRALIA
Australian Competition and Consumer Commission v Medibank Private Limited [2017] FCA 1006
File number: VID 642 of 2016 Judge: O’CALLAGHAN J Date of judgment: 30 August 2017 Catchwords: CONSUMER LAW – private health insurance – contract for the provision of insurance in respect of in-hospital pathology and radiology services – where insurer met the out-of-pocket expenses incurred by policyholders in respect of in-hospital pathology and radiology services through direct payment arrangements with providers of those services – where insurer decided to terminate certain of those payment arrangements and, upon termination of those arrangements, to pay a reduced proportion of the provider’s actual charges – whether conduct misleading or deceptive in contravention of ss 18, 29(1)(g), 29(1)(m) or 34 in Sch 2 of the Competition and Consumer Act 2010 (Cth) (“Australian Consumer Law”) – whether conduct unconscionable in contravention of s 21 of the Australian Consumer Law Legislation: Competition and Consumer Act 2010 (Cth), Sch 2, ss 18, 21, 29(1)(g), 29(1)(m), 34
Evidence Act 1995 (Cth), s 191
Health Insurance Act 1973 (Cth), ss 3 (definitions of “approved pathology practitioner”, “item”, “medicare benefit”, “medical practitioner”, “professional service” and “table”), 10, 126
Private Health Insurance Act 2007 (Cth) (as at 1 July 2014), Pts 3-2, 3-3, 3-4, 4-2 (Div 118), Pt 4-3 (Div 126) and Pt 4-4 (Div 134)
Private Health Insurance (Prudential Supervision) Act 2015 (Cth), Pt 2, Divs 2 and 3, Pt 3, Div 2
Private Health Insurance (Complying Product) Rules 2010(No. 2) (Cth) (as at 1 July 2014), r 13, Schs 1-4
Private Health Insurance (Benefits Requirements) Rules 2011 (Cth) (as at 24 July 2014), Pt 2, Schs 1-5
Cases cited: Australian Competition and Consumer Commission v Commonwealth Bank of Australia (2003) 133 FCR 149
Australian Competition and Consumer Commission v Lux Distributors Pty Ltd [2013] FCAFC 90
Australian Competition and Consumer Commission v TPG Internet Pty Ltd (2013) 250 CLR 640
Australian Competition and Consumer Commission v 4WD Systems Pty Ltd [2003] FCA 850; 200 ALR 491
Bing! Software Pty Ltd v Bing Technologies Pty Ltd (2009) 180 FCR 191
1 Butcher v Lachlan Elder Realty (2004) 218 CLR 592
2 Campbell v Backoffice Investments (2009) 238 CLR 304
Chase Manhattan Overseas Corp v Chase Corp Limited (1986) 12 FCR 375
Health Insurance Commission v Peverill (1994) 179 CLR 226
Metz Holdings Pty Ltd v Simmac Pty Ltd (No 2) [2011] FCA 981
NRM Corporation Pty Ltd v Australian Competition and Consumer Commission [2016] FCAFC 98
Perdaman Chemicals and Fertilisers Pty Ltd v ICICI Bank Ltd [2013] FCA 175
SAP Australia Pty Ltd v Sapient Aust Pty Ltd [1999] FCA 1027
SAP Australia Pty Ltd v Sapient Australia Pty Ltd [1999] FCA 1821; (1999) 169 ALR 1
Trade Practices Commission v Optus Communications Pty Ltd (1996) 64 FCR 326
Wong v Commonwealth (2009) 236 CLR 573
Biggs A, “Medicare: a Quick Guide” (Department of…
Keep reading for free
Create a free CaseChat account to read Australian Competition and Consumer Commission v Medibank Pr... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2017] FCA 1006
- Decision Date
CaseChat Overview and Summary
The court examined the evidence presented, including market research and internal communications at Medibank, which suggested that a significant portion of Medibank's members had limited understanding of private health insurance and out-of-pocket expenses. Despite these findings, the court determined that Medibank's decision not to communicate with members about the changes was a matter of business judgment and did not amount to unconscionable conduct. The court held that while some members might disagree with the decision, it did not meet the threshold of unconscionability required by law. Consequently, the court dismissed the ACCC's case, ruling that Medibank's actions did not contravene the Australian Consumer Law.
The court ordered that the proceeding be dismissed with costs, effectively concluding that Medibank's conduct did not warrant the ACCC's intervention. The decision underscores the importance of business judgment in such matters and highlights the high threshold for establishing unconscionable conduct under the Australian Consumer Law.
Orders
Orders of the court
1. The proceeding be dismissed with costs.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
After implementation of the decision, Medibank received a number of complaints from members.Consideration – unconscionability The submissions in respect of the evidence, which I have outlined and with which it is necessary to deal are as follows.Market research and Medibank’s knowledge of consumers I turn first to the market research upon which the applicant placed much store. It is not necessary to recite that evidence in any detail, because ultimately the applicant’s case was that the relevant reports and internal correspondence about them proved a series of propositions concerning information known to Medibank from early 2014 onwards, which made Medibank’s decision not to notify members of the change unconscionable. Those propositions, which rely principally upon the Sibbick memo referred to earlier and, to a lesser extent, evidence given by Dr Wilson in cross-examination, are as follows: (1)large proportions of the member base do not have a good understanding of private health insurance in general; (2)two thirds of members paid an excess in connection with hospital admissions; (3)large proportions of members who paid an excess did not expect to pay any medical out-of-pocket expenses;(4)over half of members who claimed on hospital policies (claimers) experienced medical out-of-pocket expenses;(5)one third of claimers who experienced a medical out-of-pocket expense were surprised by it;(6)around half of claimers who experienced a medical out-of-pocket expense did not qualify as having given informed financial consent to the out-of-pocket charge; (7)over half of claimers considered that medical gaps were not easy to understand; (8)seven in 10 members had no discussions about medical out-of-pocket expenses prior to their admission;(9)for claimers over 64 years of age, around eight in 10 did not contact Medibank; (10)around half of Medibank members (generally) were in the 64 year plus cohort and around 20% were on incomes less than $50,000; (11)15% of claimers who paid a medical out-of-pocket expense only, and 33% of claimers who paid a medical out-of-pocket expense and an excess, would consider switching health funds as a result; (12)over half of non-claimers felt they had a vague or poor understanding of out-of-pocket expenses prior to being informed (during surveys);(13)over half of non-claimers expected to pay no out-of-pocket expenses other than their excess; (14)one third of members would switch doctors/specialists to reduce/avoid medical out-of-pocket expenses; (15)one third of claimers who paid medical out-of-pocket expenses considered it was Medibank’s responsibility to inform them about the out-of-pocket expenses in advance; (16)if educated about the opportunity to discuss out-of-pocket expenses prior to hospital admission, 80% would do so and 80% of that cohort would approach Medibank;(17)the “surprise” of out-of-pocket expenses left a greater negative impression for members that the amount of out-of-pocket expenses; (18)members’ first interaction with in-hospital diagnostic service providers is likely to be at the hospital; and(19)members typically first became aware of medical out-of-pocket expenses when they got home from hospital and began to receive medical bills.